I don't think it's happening according to The Dales Report but who knows - GLTA !! Revive’s COVID optionality differentiates them from its psychedelic peers in terms of 2021 upside potential, while its growing pipeline of psychedelic assets remains underrated. Phase 3 Bucillamine results could be available by October or November, with the next DSMB 600-patient milestone meeting expected
...more